Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers During the COVID-19 Pandemic: A Modeling Analysis

Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) are frequently prescribed for a range of diseases including hypertension, proteinuric chronic kidney disease, and heart failure. There is evidence indicating that these drugs upregulate ACE2, a key component o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadria, Mehrshad, Layton, Anita T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575117/
https://www.ncbi.nlm.nih.gov/pubmed/33031368
http://dx.doi.org/10.1371/journal.pcbi.1008235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575117/
https://www.ncbi.nlm.nih.gov/pubmed/33031368
http://dx.doi.org/10.1371/journal.pcbi.1008235

Ejemplares similares